v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenues $ 14,915 $ 15,328 $ 30,163 $ 22,871
Costs and operating expenses:        
Cost of product revenue 3,512 2,098 5,576 4,830
Research and development 11,705 13,775 23,153 26,717
Selling, general and administrative 10,927 12,317 20,706 24,672
Total costs and operating expenses 26,144 28,190 49,435 56,219
Loss from operations (11,229) (12,862) (19,272) (33,348)
Interest income 535 584 1,200 1,335
Interest and other expense, net (1,301) (984) (2,591) (1,926)
Loss before income taxes (11,995) (13,262) (20,663) (33,939)
Provision for income taxes 10 10 46 21
Net loss $ (12,005) $ (13,272) $ (20,709) $ (33,960)
Net loss per share, basic (in dollars per share) $ (0.13) $ (0.16) $ (0.23) $ (0.40)
Net loss per share, diluted (in dollars per share) $ (0.13) $ (0.16) $ (0.23) $ (0.40)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 91,053 85,389 90,911 83,908
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 91,053 85,389 90,911 83,908
Product revenue        
Revenues:        
Total revenues $ 13,218 $ 7,380 $ 20,409 $ 13,439
Research and development revenue        
Revenues:        
Total revenues $ 1,697 $ 7,948 $ 9,754 $ 9,432

Source